Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Times Interest Earned (2016 - 2025)

Integra Lifesciences Holdings' Times Interest Earned history spans 17 years, with the latest figure at $0.97 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 48.14% year-over-year to $0.97; the TTM value through Dec 2025 reached -$5.72, down 1522.01%, while the annual FY2025 figure was -$5.72, 1522.01% down from the prior year.
  • Times Interest Earned for Q4 2025 was $0.97 at Integra Lifesciences Holdings, up from $0.52 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $5.08 in Q3 2022 and bottomed at -$24.36 in Q2 2025.
  • The 5-year median for Times Interest Earned is $1.96 (2024), against an average of $0.68.
  • The largest annual shift saw Times Interest Earned skyrocketed 339.23% in 2021 before it plummeted 14902.28% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at $4.8 in 2021, then increased by 5.76% to $5.08 in 2022, then crashed by 48.38% to $2.62 in 2023, then decreased by 28.41% to $1.88 in 2024, then tumbled by 48.14% to $0.97 in 2025.
  • Per Business Quant, the three most recent readings for IART's Times Interest Earned are $0.97 (Q4 2025), $0.52 (Q3 2025), and -$24.36 (Q2 2025).